mktcap_usd=230358
ConsensRecom=2.64
earning_yield=5.89%
growth=3.74%
dilution=-1.04%
div_ratio=57.62%
sh_payout_ratio=74.77%
margin=20.27%
cfmargin=20.83%
ratiopaid=1.01
sratiopaid=58.00%
ratioConsens=1.25
Description
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Income and Cashflow Statements CHF
| EndDate | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | mean | std |
|---|---|---|---|---|---|---|---|---|---|
| sourceDate | 2017-02-02 | 2018-02-01 | 2019-01-31 | 2020-01-30 | 2021-02-04 | 2022-02-03 | 2023-02-02 | NaN | NaN |
| period | 12M | 12M | 12M | 12M | 12M | 12M | 12M | NaN | NaN |
| rev | 50576 | 53299 | 56846 | 61466 | 58323 | 62801 | 63281 | 58085 | 4857 |
| revgrowth | NaN | 5.24% | 6.44% | 7.81% | -5.25% | 7.40% | 0.76% | 3.74% | 5.08% |
| earn | 9576 | 8633 | 10500 | 13497 | 14295 | 13930 | 12421 | 11836 | 2261 |
| earnx | 9576 | 8749 | 10465 | 13497 | 14295 | 13930 | 12421 | 11848 | 2238 |
| margin | 18.93% | 16.20% | 18.47% | 21.96% | 24.51% | 22.18% | 19.63% | 20.27% | 2.78% |
| xmargin | 18.93% | 16.41% | 18.41% | 21.96% | 24.51% | 22.18% | 19.63% | 20.29% | 2.74% |
| earningyld | 4.71% | 4.18% | 4.77% | 4.91% | 5.26% | 4.20% | 5.23% | 4.75% | 0.44% |
| cfop | 15001 | 18024 | 19979 | 22385 | 18566 | 20976 | 18415 | 19049 | 2373 |
| cfinv | -4513 | -6459 | -7195 | -8634 | -9067 | -6552 | -3536 | -6565 | 2014 |
| cffin | -10071 | -11115 | -10691 | -14173 | -9666 | -13108 | -16275 | -12157 | 2440 |
| cfopmargin | 29.66% | 33.82% | 35.15% | 36.42% | 31.83% | 33.40% | 29.10% | 32.77% | 2.72% |
| cfinvmargin | -8.92% | -12.12% | -12.66% | -14.05% | -15.55% | -10.43% | -5.59% | -11.33% | 3.34% |
| cffinmargin | -19.91% | -20.85% | -18.81% | -23.06% | -16.57% | -20.87% | -25.72% | -20.83% | 2.94% |
| shares | 870 | 870 | 870 | 874 | 875 | 870 | 818 | 864 | 20.6 |
| fx | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0 |
| price | 234 | 237 | 253 | 314 | 310 | 381 | 291 | 289 | 52.5 |
| dilution | NaN | 0 | 0 | 0.46% | 0.12% | -0.58% | -6.24% | -1.04% | 2.57% |
| dividend | 7040 | 7140 | 7253 | 7682 | 7964 | 8132 | 7832 | 7578 | 432 |
| sharebb | NaN | 0 | 0 | -1148 | -316 | 1749 | 17665 | 2992 | 7250 |
| ltdebtbb | NaN | 1153 | -238 | 2530 | 2451 | -4980 | -5315 | -733 | 3567 |
| mgtbb | NaN | -2822 | -3676 | -5109 | 433 | -8207 | 3907 | -2579 | 4254 |
| divyld | 3.46% | 3.45% | 3.29% | 2.80% | 2.93% | 2.45% | 3.29% | 3.10% | 0.38% |
| sharebbyld | NaN | 0 | 0 | -0.46% | -0.12% | 0.58% | 6.24% | 1.04% | 2.57% |
| mgtyld | NaN | -1.37% | -1.67% | -1.86% | 0.16% | -2.48% | 1.64% | -0.93% | 1.54% |
Balance Sheet
| EndDate | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | mean | std |
|---|---|---|---|---|---|---|---|---|---|
| sourceDate | 2017-02-02 | 2018-02-01 | 2019-01-31 | 2020-01-30 | 2021-02-04 | 2022-02-03 | 2023-02-02 | NaN | NaN |
| mktcap | 203213 | 206673 | 220315 | 274630 | 271753 | 331321 | 237697 | 249372 | 46168 |
| mktcapgrowth | NaN | 1.69% | 6.39% | 22.04% | -1.05% | 19.82% | -33.21% | 2.61% | 19.93% |
| totAsset | 76819 | 76676 | 78517 | 83091 | 86138 | 92317 | 88151 | 83101 | 6075 |
| assetgrowth | NaN | -0.19% | 2.37% | 5.66% | 3.60% | 6.93% | -4.62% | 2.29% | 4.21% |
| curAsset | 28670 | 31572 | 32244 | 31254 | 32942 | 35627 | 33816 | 32304 | 2183 |
| curAssetPct | 37.32% | 41.18% | 41.07% | 37.61% | 38.24% | 38.59% | 38.36% | 38.91% | 1.57% |
| totLiab | 52908 | 50235 | 50895 | 50344 | 49797 | 67828 | 60159 | 54595 | 6864 |
| totLiabPct | 68.87% | 65.52% | 64.82% | 60.59% | 57.81% | 73.47% | 68.25% | 65.62% | 5.26% |
| curLiab | 22600 | 22160 | 23033 | 24119 | 25401 | 38416 | 27239 | 26138 | 5694 |
| curLiabPct | 29.42% | 28.90% | 29.34% | 29.03% | 29.49% | 41.61% | 30.90% | 31.24% | 4.62% |
| ltDebt | 16992 | 15839 | 16077 | 13547 | 11096 | 16076 | 21391 | 15860 | 3163 |
| ltDebtPct | 22.12% | 20.66% | 20.48% | 16.30% | 12.88% | 17.41% | 24.27% | 19.16% | 3.86% |
| Equity | 23911 | 26441 | 27622 | 32747 | 36341 | 24489 | 27992 | 28506 | 4508 |
| EquityPct | 31.13% | 34.48% | 35.18% | 39.41% | 42.19% | 26.53% | 31.75% | 34.38% | 5.26% |
| PB | 8.50 | 7.82 | 7.98 | 8.39 | 7.48 | 13.5 | 8.49 | 8.88 | 2.08 |
Beta
len=131
mean=2.45%
sd=14.46%
alpha=0.31%
beta=28.01%
r_sq=11.55%
lastdate=2023-03-21
firstdate=2013-02-01
logret1y=-33.74%
Financial Snapshot
CompanyName=Roche Holding AG
ID=1
Name=Genussscheine
Ticker=ROG
ISIN=CH0012032048
RIC=ROG.S
DisplayRIC=ROG.S
InstrumentPI=468925
QuotePI=1032675
InstrumentPermID=8590927767
QuotePermID=55838849786
Exchange=SIX Swiss Exchange
ExchangeCode=SWF
ExchangeCountry=CHE
CoStatus=Active
CoType=Equity Issue
LastModified=2023-02-03
LatestAvailableAnnual=2022-12-31
LatestAvailableInterim=2022-12-31
Employees=103613
SharesOut=799180671
TotalFloat=711900861
ReportingCurrency=CHF
MostRecentExchange=0.9291
Industry=Pharmaceuticals (NEC)
IndustryCode=5620104010
NPRICE=262
NHIG=404
NLOW=257
PDATE=2023-03-17
VOL10DAVG=2.15
EV=230802
MKTCAP=214025
AREV=63281
AEBITD=23868
ANIAC=12421
AEPSXCLXOR=15.4
AREVPS=78.3
ABVPS=35.0
ACSHPS=12.2
ACFSHR=21.5
ADIVSHR=9.50
AGROSMGN=70.7
AROEPCT=47.3
APR2REV=3.38
APEEXCLXOR=17.0
APRICE2BK=7.47
ConsRecom=2.64
TargetPrice=328
ProjLTGrowthRate=5.63
ProjPE=13.4
ProjSales=61346
ProjSalesQ=15429
ProjEPS=19.5
ProjEPSQ=-100000
ProjProfit=19404
ProjDPS=9.67
quoteccy=CHF
quotefx=92.91%
exchgccy=CHF
exchgfx=92.91%
tick=None
exchg=None
Valuation
ticker=ROG
exchg=EBS
RIC=ROG.S
CompanyName=Roche Holding AG
ExchangeCode=SWF
Industry=Pharmaceuticals (NEC)
IndustryCode=5620104010
sector=56 Healthcare
region=eu
ccy=CHF
fx=92.91%
mktcap_usd=230358
float_usd=205200
ConsensRecom=2.64
earning_yield=5.89%
growth=3.74%
dilution=-1.04%
margin=20.27%
searning_yield=5.14%
sgrowth=-0.90%
smargin=17.69%
sdilution=1.31%
projearning_yield=7.19%
earning_excl_yield=5.71%
div_ratio=57.62%
bb_ratio=17.15%
sh_payout_ratio=74.77%
PS=3.34
price=262
ratio=1.01
sratio=58.00%
sratiopaid=58.00%
ratioConsens=1.25
turnover=69.89%
cfmargin=20.83%
rdmargin=20.34%
scfmargin=18.10%
quoteccy=CHF
quotefx=92.91%
ratiopaid=1.01
dt=2023-03-17
assetgrowth=2.29%
dlnfx=1.41%